Clinical trial · Interventional
Intraoperative Use of the BP Device for Detecting Positive Margins During Lumpectomy Procedure
MAST Study Protocol
NCT00380952CI-TRIAL-00001481completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This protocol was designed for testing the intraoperative use of the Dune device. This multicenter study will take place in Israel at 12 sites.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dune Device | Device | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion criteria 1. Women diagnosed with carcinoma of the breast 2. Undergoing lumpectomy (local wide excision) procedure. 3. Over 18 years of age 4. Signed ICF Exclusion criteria 1. Neoadjuvant systemic therapy 2. Previous radiation in the operated breast 3. Prior surgical procedure in the same quadrant 4. Implants in the operated breast 5. Pregnancy 6. Participating in any other investigational study for either drug or device which can influence collection of valid data under this study.
References
Publications (0)
Data not yet available
No reference posted for this study.